Hubei Jumpcan Pharmaceutical Co., Ltd. (600566) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Hubei Jumpcan Pharmaceutical Co., Ltd.

Why is Hubei Jumpcan Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 0.92% and Operating profit at 3.26% over the last 5 years

With a fall in PBT of -27.18%, the company declared Very Negative results in Sep 25

The company has declared negative results for the last 4 consecutive quarters
OPERATING CASH FLOW(Y) Lowest at CNY 1,350.62 MM
ROCE(HY) Lowest at 11.84%
INVENTORY TURNOVER RATIO(HY) Lowest at 2.94 times

Underperformed the market in the last 1 year

The stock has generated a return of 2.46% in the last 1 year, much lower than market (China Shanghai Composite) returns of 22.49%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Hubei Jumpcan Pharmaceutical Co., Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Hubei Jumpcan Pharmaceutical Co., Ltd.

-4.29%

-1.23

22.01%

China Shanghai Composite

15.17%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

0.92%

EBIT Growth (5y)

3.26%

EBIT to Interest (avg)

81.87

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.76

Sales to Capital Employed (avg)

0.57

Tax Ratio

14.86%

Dividend Payout Ratio

75.53%

Pledged Shares

Institutional Holding

ROCE (avg)

56.77%

ROE (avg)

17.31%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.70

EV to EBIT

6.92

EV to EBITDA

5.94

EV to Capital Employed

3.56

EV to Sales

1.98

PEG Ratio

Dividend Yield

8.41%

ROCE (Latest)

51.43%

ROE (Latest)

14.13%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Sideways

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Mildly Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -1.08% (YoY

-32What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 1,350.62 MM

ROCE(HY)

Lowest at 11.84%

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.94 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.47 times

NET SALES(Q)

Lowest at CNY 1,183.34 MM

PRE-TAX PROFIT(Q)

Lowest at CNY 361.39 MM

NET PROFIT(Q)

Lowest at CNY 261.8 MM

Here's what is working for Hubei Jumpcan Pharmaceutical Co., Ltd.

Raw Material Cost

Fallen by -1.08% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Hubei Jumpcan Pharmaceutical Co., Ltd.

Net Sales

At CNY 1,183.34 MM has Fallen at -29.68%

over average net sales of the previous four periods of CNY 1,682.8 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CNY MM)

Operating Cash Flow

Lowest at CNY 1,350.62 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Profit

At CNY 261.8 MM has Fallen at -45.03%

over average net sales of the previous four periods of CNY 476.27 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Net Sales

Lowest at CNY 1,183.34 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Pre-Tax Profit

Lowest at CNY 361.39 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Pre-Tax Profit

At CNY 361.39 MM has Fallen at -35.61%

over average net sales of the previous four periods of CNY 561.23 MM

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit

Lowest at CNY 261.8 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

Inventory Turnover Ratio

Lowest at 2.94 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 3.47 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio